Moreover, SAA1 had the ability to stimulate NF-κBp65 protein transportation from the cytoplasm to the nucleus and activate the NF-κB pathway which mediated NASH progression (40). The gene discussed is SAA1; the disease is metabolic dysfunction-associated steatohepatitis.